Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Huajiang Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company is recognized as one of the world's largest producers of Paracetamol (Acetaminophen) and also manufactures other key products such as Guaifenesin and Methocarbamol. Huajiang operates high-standard manufacturing facilities that comply with international GMP standards, serving a global clientele across the pharmaceutical industry. In addition to its core API business, the company provides contract manufacturing (CMO) services and continues to expand its portfolio of chemical intermediates for various therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hua Jiang.